Selegiline is an antiparkinson medication that acts as a selective monoamine oxidase-B (MAO-B) inhibitor. It is primarily used to manage symptoms of Parkinson's disease by increasing dopamine levels in the brain. By preventing the breakdown of dopamine, Selegiline helps improve motor function and reduce symptoms such as tremors and rigidity. Common side effects may include nausea, dizziness, and insomnia. In summary, Selegiline plays a crucial role in the management of Parkinson's disease.
Selegiline selectively inhibits the enzyme monoamine oxidase-B, leading to increased levels of dopamine in the brain and improved symptoms of Parkinson's disease.
No published brands for this salt yet.